Ken Griffin
AMYT

Ken Griffin’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Ken Griffin’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,900
Closed -$13.9K – 15998
2022
Q4 		$13.9K Buy
+1,900
New +$13.4K ﹤0.01% 13420

Other funds holding AMYT

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Ken Griffin's AMYT Position: Q1 2023 in Review

Ken Griffin sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 41,280 shares — an estimated $301K sold.

Ken Griffin first reported a position in AMYT in Q2 2021 and held it in 7 quarters. The position peaked at $640K in Q2 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Ken Griffin reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Ken Griffin sold 41,280 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $301K.
  • Ken Griffin first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2021 and held it in 7 quarters.
  • Ken Griffin's Amryt Pharma plc American Depositary Shares position peaked at $640K in Q2 2022.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.